Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?


OverviewForecastRevenueFinancialsChart

Bicycle Therapeutics Ownership Summary


Bicycle Therapeutics is owned by 0.10% institutional investors, 1.46% insiders, and 98.44% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.73% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.58% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBicycle Therapeutics0.10%1.46%98.44%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp10.89M15.73%$92.42M
Point72 asset management4.55M6.60%$63.77M
Fcpm iii services b.v.3.45M5.00%$48.33M
Westfield capital management co lp2.61M3.78%$36.54M
Armistice capital2.20M3.18%$30.74M
Morgan stanley1.23M2.89%$24.93M
Siren1.84M2.67%$25.75M
Price t rowe associates inc /md/1.59M2.30%$22.19M
Tybourne capital management (hk)1.27M1.84%$17.77M
Bnp paribas asset management1.16M1.68%$16.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.3.45M8.16%$48.33M
Tybourne capital management (hk)1.27M4.46%$17.77M
Aquilo capital management171.69K2.61%$1.46M
Siren1.84M1.14%$25.75M
Baker bros. advisors lp10.89M1.02%$92.42M
Ecor1 capital910.00K0.48%$12.74M
Nan fung group68.94K0.48%$585.33K
Armistice capital2.20M0.42%$30.74M
Palo alto investors lp248.93K0.40%$2.11M
Platinum investment management309.06K0.25%$4.33M

Top Buyers

HolderShares% AssetsChange
Point72 asset management4.55M0.14%3.66M
Siren1.84M1.14%1.84M
Fcpm iii services b.v.3.45M8.16%1.11M
Westfield capital management co lp2.61M0.16%759.39K
Long focus capital management543.09K0.25%543.09K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---3.25M
Polar capital---1.00M
First light asset management---967.01K
Camber capital management lp---915.00K
Suvretta capital management---914.48K

New Positions

HolderShares% AssetsChangeValue
Siren1.84M1.14%1.84M$25.75M
Long focus capital management543.09K0.25%543.09K$7.60M
Caption management163.08K0.02%163.08K$2.28M
Group one trading466.00-466.00$6.52M
Td waterhouse canada100.00-100.00$1.40K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Mather group, llc.-5.00
Northwestern mutual wealth management-5.00
Steward partners investment advisory-10.00
Eversource wealth advisors-13.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251-99.00%68,943-99.84%-0.00%--100.00%--100.00%
Dec 31, 202499-10.00%41,889,6823.58%601.77%44-16.98%3612.50%
Sep 30, 20241101.85%40,440,4271.84%581.00%55-9.84%3228.00%
Jun 30, 202410711.46%39,708,44130.36%931.81%6042.86%25-24.24%
Mar 31, 202496-10.28%30,461,275-2.88%711.14%42-25.00%333.13%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
T. Rowe Price Health Sciences1.09M1.58%-41.23K
Harbor Small Cap Growth Instl970.00K1.40%-30.82K
Westfield Capital Mgt Co Sm-Cap Gr Eq970.00K1.40%-30.82K
Candriam Eqs L Biotech C USD Cap805.24K1.16%182.36K
BNP Paribas Health Cr Innovtr Cl Cap568.54K0.82%106.00
Candriam Global Equities Oncology492.11K0.71%125.18K
BNP Paribas US Small Cap ClassicC475.21K0.69%7.16K
BNP Paribas US Small Cap Classic R468.06K0.68%-9.43K
Belfius Equities Cure C Cap367.15K0.53%-
MEDICAL BioHealth EUR Acc343.42K0.50%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 03, 2025Lee Kevin CHIEF EXECUTIVE OFFICERSell$23.76K
Jul 02, 2025Lee Kevin CHIEF EXECUTIVE OFFICERSell$16.08K
Jul 02, 2025Skynner Michael CHIEF TECHNOLOGY OFFICERSell$5.85K
Jul 03, 2025Skynner Michael CHIEF TECHNOLOGY OFFICERSell$7.19K
Jul 02, 2025Milnes Alistair CHIEF OPERATING OFFICERSell$8.15K

Insider Transactions Trends


DateBuySell
2025 Q1-15
2024 Q41011
2024 Q3-7
2024 Q2-7
2024 Q1-6

BCYC Ownership FAQ


Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 0.10%, followed by 1.46% insiders and 98.44% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 64.05%, which Bicycle Therapeutics falls below.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (10.89M shares, 15.73%), Point72 asset management (4.55M shares, 6.60%), and Fcpm iii services b.v. (3.45M shares, 5.00%). Together, they hold 27.34% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicycle Therapeutics.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.16% of its assets in 3.45M Bicycle Therapeutics shares, valued at 48.33M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Bicycle Therapeutics shares, with 1.58% of its total shares outstanding invested in 1.09M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools